The automated real-time PCR-based test detects DNA from the virus that causes mpox using a dual-target approach and runs on Roche's high-throughput Cobas 6800/8800 systems. The EUL process is intended ...
The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...
In September 2024, Mainz Biomed announced encouraging feedback received from the FDA for the breakthrough device designation with the request to expand the current clinical data set with additional ...